Enyrgy Inc

Enyrgy Inc. is a private health technology company that builds a home UVB device called the Enyrgy Vitamin D Primal Light Platform. The device emits a spectrum verified by an independent laboratory (approximately 90–95% UVB and 5–10% UVA) and runs two- to four-minute sessions that the app doses and automatically shuts off based on a user’s skin type. The platform is designed to support vitamin D synthesis, nitric oxide release and serotonin activation and includes safety controls and an MED-based protocol.

The company publishes clinical and observational data from a 12-week cohort study and maintains a scientific advisory board and a medical director to oversee protocol and safety. Enyrgy sells the platform via its shop, reports over 25,000 sessions completed and 600+ users across five countries, and notes HSA/FSA eligibility through Truemed.